Search Results | American Association for Cancer Research

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Abstract 3618: PELP1 cytoplasmic mislocalization favors estrogen-induced signaling via AIB1 in ER+ breast cancer models

Thu H. Truong, Julie H. Ostrander, Carol A. Lange

Cancer Res (2017) 77 (13_Supplement): 3618.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3618

Published: 01 July 2017

View article

Journal Articles

Abstract 3617: A paradigm shift for insulin-like growth factor 1 receptor function in triple negative breast cancers

Alison Obr, Sushil Kumar, Raymond Birge, Teresa Wood

Cancer Res (2017) 77 (13_Supplement): 3617.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3617

Published: 01 July 2017

View article

Journal Articles

Abstract 3610: Synergy between androgen receptor (AR)-targeting agents seviteronel (SEVI) or enzalutamide (ENZA) and mTOR or HER2 pathway-targeting agents in breast cancer

Michael A. Gordon, Nicholas D'Amato, Jessica Christenson, Beatrice Babbs, Haihua Gu, Julia Wulfkuhle, Emmanuel Petricoin, Anthoy Elias, Jennifer K. Richer

Cancer Res (2017) 77 (13_Supplement): 3610.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3610

Published: 01 July 2017

View article

Journal Articles

Abstract 3603: Optimizing combination therapy against antiestrogen-resistance in estrogen receptor positive breast cancer

Lauren M. Gutgesell, Rui Xiong, Jiong Zhao, Debra A. Tonetti, Gregory R. Thatcher

Cancer Res (2017) 77 (13_Supplement): 3603.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3603

Published: 01 July 2017

View article

Journal Articles

Abstract 3624: CAR T cells targeting ICAM-1 trigger strong antitumor effects against advanced human thyroid tumors

Irene M. Min, Yogindra Vedvyas, Enda Shevlin, Marjan Zaman, Brian Wyrwas, Weibin Wang, Susan Park, Maureen Moore, Theresa Scognamiglio, Rasa Zarnegar, Thomas J. Fahey, Moonsoo M. Jin

Cancer Res (2017) 77 (13_Supplement): 3624.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3624

Published: 01 July 2017

View article

Journal Articles

Abstract 3605: The role of androgen receptor in invasive lobular breast carcinoma

Hillary Stires, Rebecca B. Riggins

Cancer Res (2017) 77 (13_Supplement): 3605.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3605

Published: 01 July 2017

View article

Journal Articles

Abstract 3616: Potential therapeutic use of Estrogen Receptor β agonist in the prevention and progression of breast cancer using HER-2/neu mouse model

Kumaraguruparan Ramasamy, Cathy Samayoa, Naveen K. Krishnegowda, Ratna K. Vadlamudi, Rajeshwar R. Tekmal

Cancer Res (2017) 77 (13_Supplement): 3616.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3616

Published: 01 July 2017

View article

Journal Articles

Abstract 3606: RBP2 promotes tamoxifen resistance by altering ER function and activating IGF1R and EGFR/HER2 signaling in histone methylation-dependent and -independent manners in breast cancer

Hee-Joo Choi, Taekwon Son, Hyung-Yong Kim, Kyueng-Whan Min, Young-Ha Oh, Jeong-Yeon Lee, Gu Kong

Cancer Res (2017) 77 (13_Supplement): 3606.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3606

Published: 01 July 2017

View article

Journal Articles

Abstract 3619: Role of MTDH in estrogen-regulated gene expression

Xiangbing Meng, Yujun Li, Jesus Gonzalez Bosquet, shujie yang, Kristina W. Thiel, Kimberly K. Leslie

Cancer Res (2017) 77 (13_Supplement): 3619.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3619

Published: 01 July 2017

View article

Journal Articles

Abstract 3607: Metastasis-associated protein 1 negatively regulates expression of androgen receptor in ER-positive breast cancer cells

SeungSu Kim

Cancer Res (2017) 77 (13_Supplement): 3607.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3607

Published: 01 July 2017

View article

Journal Articles

Abstract 3627: Validation of PPARG and RXRA as drivers of bladder cancer

Jonathan T. Goldstein, Craig Strathdee, Fujiko Duke, Juliann Shih, Matthew Meyerson

Cancer Res (2017) 77 (13_Supplement): 3627.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3627

Published: 01 July 2017

View article

Journal Articles

Abstract 3625: Thyroid hormone, thyroxine, promotes cell proliferation and β-catenin activation in colorectal cancer

Yee-Shin Lee, Meng-Ti Hsieh, Yu-Tang Chin, Aleck Hercbergs, Paul J. Davis, Han-Chung Wu, Hung-Yun Lin

Cancer Res (2017) 77 (13_Supplement): 3625.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3625

Published: 01 July 2017

View article

Journal Articles

Abstract 3622: Crosstalk between automethylation and phosphorylation tightly regulates G9a and GLP coactivator function with steroid hormone receptors

Coralie Poulard, Michael Stallcup

Cancer Res (2017) 77 (13_Supplement): 3622.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3622

Published: 01 July 2017

View article

Journal Articles

Abstract 3608: RAD140, an orally available selective androgen receptor modulator, inhibits the growth of AR/ER positive breast cancer cell line- and patient-derived xenograft models

Ziyang Yu, Suqin He, Jeffrey Brown, Chris Miller, Jamal Saeh, Gary Hattersley

Cancer Res (2017) 77 (13_Supplement): 3608.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3608

Published: 01 July 2017

View article

Journal Articles

Abstract 3612: Combination FGFR4 and ER-targeted therapy for invasive lobular carcinoma

Kevin Levine, Jian Chen, Matthew Sikora, Nilgun Tasdemir, George Tseng, Shannon Puhalla, Rachel Jankowitz, David Dabbs, Priscilla McAuliffe, Adrian Lee, Steffi Oesterreich

Cancer Res (2017) 77 (13_Supplement): 3612.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3612

Published: 01 July 2017

View article

Journal Articles

Abstract 3621: Characterization of the effects of estrogen receptor alpha Y537S and D538G mutations on receptor pharmacology

Steven J. Hartman, Tracy Kleinheinz, Jonathan White, Stephen Daly, Ria Goodwin, Wei Zhou, Jun Liang, Xiaojing Wang, Daniel F. Ortwine, Lori Friedman, Martin O’Rourke, Ciara Metcalfe, Robert A. Blake

Cancer Res (2017) 77 (13_Supplement): 3621.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3621

Published: 01 July 2017

View article

Journal Articles

Abstract 3620: RARalpha interactome in breast cancer, the S100 calcium binding protein A3 binds tothe retinoid receptor

Mineko Terao

Cancer Res (2017) 77 (13_Supplement): 3620.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3620

Published: 01 July 2017

View article

Journal Articles

Abstract 3609: RAD140, a selective androgen receptor modulator, has a differentiated mechanism of action in AR/ER positive breast cancers

Ziyang Yu, Suqin He, Dannie Wang, Jeffrey Brown, Jamal Saeh, Gary Hattersley

Cancer Res (2017) 77 (13_Supplement): 3609.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3609

Published: 01 July 2017

View article

Journal Articles

Abstract 3604: Effect of a new oral SERD AZD9496 on ER mediated signaling in xenograft model of postmenopausal breast cancer

Gauri J. Sabnis, Armina Kazi, Amanda Schech, Stephen Yu, Olga Golubeva, Angela Brodie

Cancer Res (2017) 77 (13_Supplement): 3604.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3604

Published: 01 July 2017

View article

Journal Articles

Abstract 3623: Preclinical efficacy of the selective GR antagonist, CORT125134

Hazel Hunt, Joseph Belanoff, Thad Block, Stacie P. Shepherd

Cancer Res (2017) 77 (13_Supplement): 3623.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3623

Published: 01 July 2017

View article

NARROW

Abstract 3618: PELP1 cytoplasmic mislocalization favors estrogen-induced signaling via AIB1 in ER+ breast cancer models

Abstract 3617: A paradigm shift for insulin-like growth factor 1 receptor function in triple negative breast cancers

Abstract 3610: Synergy between androgen receptor (AR)-targeting agents seviteronel (SEVI) or enzalutamide (ENZA) and mTOR or HER2 pathway-targeting agents in breast cancer

Abstract 3603: Optimizing combination therapy against antiestrogen-resistance in estrogen receptor positive breast cancer

Abstract 3624: CAR T cells targeting ICAM-1 trigger strong antitumor effects against advanced human thyroid tumors

Abstract 3605: The role of androgen receptor in invasive lobular breast carcinoma

Abstract 3616: Potential therapeutic use of Estrogen Receptor β agonist in the prevention and progression of breast cancer using HER-2/neu mouse model

Abstract 3606: RBP2 promotes tamoxifen resistance by altering ER function and activating IGF1R and EGFR/HER2 signaling in histone methylation-dependent and -independent manners in breast cancer

Abstract 3619: Role of MTDH in estrogen-regulated gene expression

Abstract 3607: Metastasis-associated protein 1 negatively regulates expression of androgen receptor in ER-positive breast cancer cells

Abstract 3627: Validation of PPARG and RXRA as drivers of bladder cancer

Abstract 3625: Thyroid hormone, thyroxine, promotes cell proliferation and β-catenin activation in colorectal cancer

Abstract 3622: Crosstalk between automethylation and phosphorylation tightly regulates G9a and GLP coactivator function with steroid hormone receptors

Abstract 3608: RAD140, an orally available selective androgen receptor modulator, inhibits the growth of AR/ER positive breast cancer cell line- and patient-derived xenograft models

Abstract 3612: Combination FGFR4 and ER-targeted therapy for invasive lobular carcinoma

Abstract 3621: Characterization of the effects of estrogen receptor alpha Y537S and D538G mutations on receptor pharmacology

Abstract 3620: RARalpha interactome in breast cancer, the S100 calcium binding protein A3 binds tothe retinoid receptor

Abstract 3609: RAD140, a selective androgen receptor modulator, has a differentiated mechanism of action in AR/ER positive breast cancers

Abstract 3604: Effect of a new oral SERD AZD9496 on ER mediated signaling in xenograft model of postmenopausal breast cancer

Abstract 3623: Preclinical efficacy of the selective GR antagonist, CORT125134

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only